Trxade Health, Inc. (NASDAQ: MEDS), a leading health services IT company, and its wholly owned subsidiary Scienture, LLC revealed that Trxade has
Trxade Group Inc.
-(MEDS)
XNAS:MEDS
Trxade Health (MEDS) Q2 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform with a mission to revolutionize the healthcare industry by offering
MEDS Earnings: A snapshot of Trxade’s Q2 2024 results
Health services IT company Trxade Health, Inc. (NASDAQ: MEDS) announced financial results for the second quarter of 2024, reporting a narrower net
Trxade Health closes business combination with Scienture in $103Mln deal
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, has announced the closing of its business combination with New York-based
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a
Earnings: Trxade Health (MEDS) reports lower revenues for fiscal 2023
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decline in revenues for fiscal 2023. The company’s full-year
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy experience. Having
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the third quarter of 2023. There was
Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of
MEDS Earnings: Highlights of Trxade Health’s Q2 2023 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter of fiscal
Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the latest such
Superlatus names Dr. Eugenio Bortone COO; interim CEO Tim Alford to become CCO
Superlatus, Inc., a holding company of food products and distribution capabilities, on Tuesday, announced new appointments to its management team. The company
Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform
Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be acquired by
TRxADE HEALTH Inc (MEDS) Q1 2023 Earnings Call Transcript
TRxADE HEALTH Inc (NASDAQ: MEDS) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Prashant Patel -- Interim Chief Financial Officer Suren Ajjarapu -- Chairman and
MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31%
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter of fiscal
Trxade Health Inc. (NASDAQ: MEDS) Q1 2023 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform. It is
Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a platform to
TRxADE HEALTH Inc (MEDS) Q4 2022 Earnings Call Transcript
TRxADE HEALTH Inc (NASDAQ:MEDS) Q4 2022 Earnings Call dated Mar. 27, 2023. Corporate Participants: Prashant Patel -- Chief Financial Officer Surendra Ajjarapu -- Founder, Chairman and
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company's
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent pharmacy market